Clinical Trials Logo

Clinical Trial Summary

To determine the impact of Midazolam levels in follicular fluid on morpho-kinetics and morpho-genetics. The reason to measure Midazolam levels in larger size follicles in this study is to maximize the chances to get a mature oocyte and therefore develop into a potential embryo to be analyzed.


Clinical Trial Description

The correlation of Midazolam levels in follicular fluid and euploid status of the embryos is worth exploring as no data exists that suggests any influence on the quality of the embryos from using this substance for IVF since its earliest days. Measuring time lapsed from injection to first oocyte retrieval as well as time lapsed in between first and last oocyte retrieved will grand insight into the rise of levels of Midazolam inside the follicular fluid, correlated with the chromosomal status and the morphokinetic development of the euploid embryos. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03049293
Study type Interventional
Source ART Fertility Clinics LLC
Contact
Status Terminated
Phase Early Phase 1
Start date June 20, 2017
Completion date October 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT05334537 - Effect of Aromatherapy on Perioperative Anxiety Level in Cesarean Sections N/A
Completed NCT03406936 - Sedation and Ease of Weaning From Mechanical Ventilation N/A